Influence of therapy continuous positive airway pressure on arterial stiffness in patients with arterial hypertension and obstructive sleep apnea

O. Rekovets, Y. Sirenko, N. Krushynska, O. Torbas
{"title":"Influence of therapy continuous positive airway pressure on arterial stiffness in patients with arterial hypertension and obstructive sleep apnea","authors":"O. Rekovets, Y. Sirenko, N. Krushynska, O. Torbas","doi":"10.31928/2664-4479-2022.5-6.1729","DOIUrl":null,"url":null,"abstract":"The aim – to assess the arterial stiffness changes in patients with arterial hypertension (AH) and obstructive sleep apnea (OSA) and possibilities of its correction by continuous positive airway pressure (CPAP)-therapy.Materials and methods. 185 patients with mild and moderate AH (49.8±0.8 years old) were enrolled in the study and divided into groups: 1st group – patients who had OSA (n=148), 2nd group – patients without OSA (control group, n=37). They underwent clinical and special examination: unattended somnography by dual-channel portable monitor device, estimation of daily sleepiness by Epworth Sleepiness Scale, office and ambulatory blood pressure monitoring, echocardiography and applanation tonometry. In 10 months follow-up study were included 105 patients, who were divided into 4 subgroups: A – patients with moderate to severe OSA on CPAP (n=23); B – patients with moderate to severe OSA without CPAP (n=29); C – patients with mild OSA (n=29); D – patients without OSA (controls, n=24). All patients received similar antihypertensive therapy according to 2013 ESH/ESC Guidelines.Results and discussion. Patients with AH and OSA (mean apnea-hypopnea index (AHI) 38.10±2.51 event/h) in comparison with patients without OSA (mean AHI 3.02±0.25 event/h) had significantly higher body mass index (35.20±0.57 vs 30.60±0.79 kg/m, p<0.001), blood glucose level (107.2±2.2 vs 98.0±2.5 mg/dl, p=0.045), uric acid level (6.17±0.10 vs 5.5±0.3 mg/dl, p=0.048) and left ventricular mass index (LVMI) (115.80±2.39 vs 104.60±4.56 g/m, p=0.035). Also the patients with AH and OSA in comparison with patients without OSA had higher carotid-femoral pulse wave velocity (PWVcf) (11.19±0.20 vs 10.10 m/s, p=0.014) and central systolic blood pressure (CSBP) (133.43±1.67 vs 125.22±3.41 mm Hg, p=0.027). During 10 month follow-up in patients with AH and OSA on CPAP-therapy there were significantly decrease of PWVcf (from 12.20±0.63 to 10.05±0.43 m/s, p=0.009) with achievement of normal level (<10 m/s) in 60.9 % patients, office systolic blood pressure (from 143.8±132.7 to 132.70±2.33 mm Hg, p=0.021) and diastolic blood pressure (from 93.80±3.31 to 86.00±3.19 mm Hg, p=0.012) with achievement of target levels. In patients central systolic BP decreased (from 130.30±3.97 to 119.70±2.97 mm Hg, p=0.012) and diastolic BP decreased (from 94.70±3.31 to 87.10±2.36 mm Hg, p=0.013).Conclusions. Combination of continuous positive airway pressure (CPAP)-therapy and antihypertensive treatment had decrease of arterial stiffness and helps to achieve target blood pressure in patients with AH and moderate to severe OSA.","PeriodicalId":23419,"journal":{"name":"Ukrainian Journal of Cardiology","volume":"43 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ukrainian Journal of Cardiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31928/2664-4479-2022.5-6.1729","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The aim – to assess the arterial stiffness changes in patients with arterial hypertension (AH) and obstructive sleep apnea (OSA) and possibilities of its correction by continuous positive airway pressure (CPAP)-therapy.Materials and methods. 185 patients with mild and moderate AH (49.8±0.8 years old) were enrolled in the study and divided into groups: 1st group – patients who had OSA (n=148), 2nd group – patients without OSA (control group, n=37). They underwent clinical and special examination: unattended somnography by dual-channel portable monitor device, estimation of daily sleepiness by Epworth Sleepiness Scale, office and ambulatory blood pressure monitoring, echocardiography and applanation tonometry. In 10 months follow-up study were included 105 patients, who were divided into 4 subgroups: A – patients with moderate to severe OSA on CPAP (n=23); B – patients with moderate to severe OSA without CPAP (n=29); C – patients with mild OSA (n=29); D – patients without OSA (controls, n=24). All patients received similar antihypertensive therapy according to 2013 ESH/ESC Guidelines.Results and discussion. Patients with AH and OSA (mean apnea-hypopnea index (AHI) 38.10±2.51 event/h) in comparison with patients without OSA (mean AHI 3.02±0.25 event/h) had significantly higher body mass index (35.20±0.57 vs 30.60±0.79 kg/m, p<0.001), blood glucose level (107.2±2.2 vs 98.0±2.5 mg/dl, p=0.045), uric acid level (6.17±0.10 vs 5.5±0.3 mg/dl, p=0.048) and left ventricular mass index (LVMI) (115.80±2.39 vs 104.60±4.56 g/m, p=0.035). Also the patients with AH and OSA in comparison with patients without OSA had higher carotid-femoral pulse wave velocity (PWVcf) (11.19±0.20 vs 10.10 m/s, p=0.014) and central systolic blood pressure (CSBP) (133.43±1.67 vs 125.22±3.41 mm Hg, p=0.027). During 10 month follow-up in patients with AH and OSA on CPAP-therapy there were significantly decrease of PWVcf (from 12.20±0.63 to 10.05±0.43 m/s, p=0.009) with achievement of normal level (<10 m/s) in 60.9 % patients, office systolic blood pressure (from 143.8±132.7 to 132.70±2.33 mm Hg, p=0.021) and diastolic blood pressure (from 93.80±3.31 to 86.00±3.19 mm Hg, p=0.012) with achievement of target levels. In patients central systolic BP decreased (from 130.30±3.97 to 119.70±2.97 mm Hg, p=0.012) and diastolic BP decreased (from 94.70±3.31 to 87.10±2.36 mm Hg, p=0.013).Conclusions. Combination of continuous positive airway pressure (CPAP)-therapy and antihypertensive treatment had decrease of arterial stiffness and helps to achieve target blood pressure in patients with AH and moderate to severe OSA.
持续气道正压治疗对动脉高血压合并阻塞性睡眠呼吸暂停患者动脉僵硬度的影响
目的是评估动脉高血压(AH)和阻塞性睡眠呼吸暂停(OSA)患者的动脉硬度变化以及持续气道正压通气(CPAP)治疗对其纠正的可能性。材料和方法。185例轻中度AH患者(49.8±0.8岁)被纳入研究,分为两组:第一组有OSA患者(n=148),第二组无OSA患者(对照组,n=37)。他们接受了临床和特殊检查:使用双通道便携式监护仪进行无人监护的睡眠描记,使用Epworth嗜睡量表评估每日嗜睡程度,办公室和动态血压监测,超声心动图和压胸测压。在10个月的随访研究中纳入105例患者,将其分为4个亚组:A - CPAP治疗中重度OSA患者(n=23);B -无CPAP的中重度OSA患者(n=29);C -轻度OSA患者(n=29);D -无OSA患者(对照组,n=24)。所有患者均按照2013年ESH/ESC指南接受类似的降压治疗。结果和讨论。AH合并OSA患者(平均呼吸暂停-低通气指数(AHI) 38.10±2.51事件/h)的体重指数(35.20±0.57 vs 30.60±0.79 kg/m, p<0.001)、血糖水平(107.2±2.2 vs 98.0±2.5 mg/dl, p=0.045)、尿酸水平(6.17±0.10 vs 5.5±0.3 mg/dl, p=0.048)和左心室质量指数(LVMI)(115.80±2.39 vs 104.60±4.56 g/m, p=0.035)显著高于无OSA患者(平均AHI 3.02±0.25事件/h)。与非OSA患者相比,AH合并OSA患者颈股动脉脉波速度(PWVcf)(11.19±0.20 vs 10.10 m/s, p=0.014)和中枢收缩压(CSBP)(133.43±1.67 vs 125.22±3.41 mm Hg, p=0.027)较高。经cpap治疗的AH合并OSA患者随访10个月,60.9%患者PWVcf(从12.20±0.63降至10.05±0.43 m/s, p=0.009)达到正常水平(<10 m/s),收缩压(从143.8±132.7降至132.70±2.33 mm Hg, p=0.021)和舒张压(从93.80±3.31降至86.00±3.19 mm Hg, p=0.012)达到目标水平。患者中央收缩压下降(从130.30±3.97降至119.70±2.97 mm Hg, p=0.012),舒张压下降(从94.70±3.31降至87.10±2.36 mm Hg, p=0.013)。持续气道正压治疗(CPAP)联合降压治疗可降低AH合并中重度OSA患者的动脉僵硬度,有助于达到目标血压。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.10
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信